The drugmaker on Friday said it will stop developing the twice-daily treatment, danuglipron, after obese patients taking the drug lost significant weight but experienced high rates of adverse side ...
The Centers for Disease Control and Prevention on Thursday released new body mass index charts for children in response to the growing obesity crisis in the U.S. The previous BMI chart for children ...
Obesity is a disease defined as an excess of adipose or fat tissue that can produce adverse health effects. It is currently the most common chronic disease in the United States. Over half of American ...
Children struggling with obesity should be evaluated and treated early and aggressively, including with medications for kids as young as 12 and surgery for those as young as 13, according to new ...
For the first time in more than a decade, the number of states with rates of obesity of 35% or more has dropped, an encouraging sign that America's epidemic of excess weight might be improving. But ...
A new study suggests that the cause of rampant obesity in America is cheap, tempting food that is convenient to eat, NBC News reported. "If we want to solve the obesity problem, we have to figure out ...
The CEO of Novo Nordisk is defending the high cost of Ozempic and Wegovy in America, saying the blockbuster drugs are ultimately saving taxpayers money on obesity-related costs. “If you look at just ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results